Sourcing disease state serum and plasma is complex, time-consuming, and often unavailable—creating challenges for diagnostic assay development. That’s why Biosynth offers human hybrid IgM monoclonal antibodies as a reliable alternative to IgM plasma. These novel alternatives offer: Lot-to-lot consistency High specificity ISO13485-certified production A reliable source Inquire about Biosynth’s human hybrid IgM monoclonal antibodies today https://lnkd.in/emXx4MQH Learn more about the role of disease state matrices, the limitations of IgM plasma, and Biosynth’s hybrid IgM antibody solution in our blog https://lnkd.in/e-uMzWHF #diagnostics #assaydevelopment #plasma #serum #diseasestateplasma #antibodies #controls
